106 related articles for article (PubMed ID: 20704521)
1. Proteomic profiling of peritoneal rinse fluid sediment separates patients with ovarian cancer from women admitted for cesarean section. A pilot study.
Honoré B; Vorum H; Knudsen A
Scand J Clin Lab Invest; 2010 Nov; 70(7):470-7. PubMed ID: 20704521
[TBL] [Abstract][Full Text] [Related]
2. Protein expression patterns associated with advanced stage ovarian cancer.
Cortesi L; Rossi E; Della Casa L; Barchetti A; Nicoli A; Piana S; Abrate M; La Sala GB; Federico M; Iannone A
Electrophoresis; 2011 Aug; 32(15):1992-2003. PubMed ID: 21728179
[TBL] [Abstract][Full Text] [Related]
3. Proteomic tracking of serum protein isoforms as screening biomarkers of ovarian cancer.
Ahmed N; Oliva KT; Barker G; Hoffmann P; Reeve S; Smith IA; Quinn MA; Rice GE
Proteomics; 2005 Nov; 5(17):4625-36. PubMed ID: 16220531
[TBL] [Abstract][Full Text] [Related]
4. Proteomic analysis and identification of new biomarkers and therapeutic targets for invasive ovarian cancer.
Jones MB; Krutzsch H; Shu H; Zhao Y; Liotta LA; Kohn EC; Petricoin EF
Proteomics; 2002 Jan; 2(1):76-84. PubMed ID: 11788994
[TBL] [Abstract][Full Text] [Related]
5. Proteomic identification of tumor-associated protein in ovarian serous cystadenocarinoma.
Li XQ; Zhang SL; Cai Z; Zhou Y; Ye TM; Chiu JF
Cancer Lett; 2009 Mar; 275(1):109-16. PubMed ID: 19056166
[TBL] [Abstract][Full Text] [Related]
6. Large-scale proteomics analysis of human ovarian cancer for biomarkers.
Bengtsson S; Krogh M; Szigyarto CA; Uhlen M; Schedvins K; Silfverswärd C; Linder S; Auer G; Alaiya A; James P
J Proteome Res; 2007 Apr; 6(4):1440-50. PubMed ID: 17315909
[TBL] [Abstract][Full Text] [Related]
7. [Identification of new ovarian cancer biomarkers with proteomic analyses--the diagnostic tool of the future?].
Petri AL; Høgdall E; Engelholm SA; Christensen IJ; Kjaer SK; Høgdall CK
Ugeskr Laeger; 2007 Aug; 169(33):2614-9. PubMed ID: 17725906
[TBL] [Abstract][Full Text] [Related]
8. Biomarkers of chemotherapy resistance in breast cancer identified by proteomics: current status.
Hodgkinson VC; Eagle GL; Drew PJ; Lind MJ; Cawkwell L
Cancer Lett; 2010 Aug; 294(1):13-24. PubMed ID: 20176436
[TBL] [Abstract][Full Text] [Related]
9. Proteomic search for potential diagnostic markers and therapeutic targets for ovarian clear cell adenocarcinoma.
Morita A; Miyagi E; Yasumitsu H; Kawasaki H; Hirano H; Hirahara F
Proteomics; 2006 Nov; 6(21):5880-90. PubMed ID: 17022098
[TBL] [Abstract][Full Text] [Related]
10. Comprehensive analysis of conditioned media from ovarian cancer cell lines identifies novel candidate markers of epithelial ovarian cancer.
Gunawardana CG; Kuk C; Smith CR; Batruch I; Soosaipillai A; Diamandis EP
J Proteome Res; 2009 Oct; 8(10):4705-13. PubMed ID: 19663500
[TBL] [Abstract][Full Text] [Related]
11. Apolipoprotein A1 as a potential biomarker in the ascitic fluid for the differentiation of advanced ovarian cancers.
Hariprasad G; Hariprasad R; Kumar L; Srinivasan A; Kola S; Kaushik A
Biomarkers; 2013 Sep; 18(6):532-41. PubMed ID: 23902290
[TBL] [Abstract][Full Text] [Related]
12. Proteomic analysis of peritoneal fluid in women with endometriosis.
Ferrero S; Gillott DJ; Remorgida V; Anserini P; Leung KY; Ragni N; Grudzinskas JG
J Proteome Res; 2007 Sep; 6(9):3402-11. PubMed ID: 17676783
[TBL] [Abstract][Full Text] [Related]
13. Proteins' promise--progress and challenges in ovarian cancer proteomics.
Koehn H; Oehler MK
Menopause Int; 2007 Dec; 13(4):148-53. PubMed ID: 18088525
[TBL] [Abstract][Full Text] [Related]
14. Clinical proteomics and mass spectrometry profiling for cancer detection.
Solassol J; Jacot W; Lhermitte L; Boulle N; Maudelonde T; Mangé A
Expert Rev Proteomics; 2006 Jun; 3(3):311-20. PubMed ID: 16771703
[TBL] [Abstract][Full Text] [Related]
15. Classifications of ovarian cancer tissues by proteomic patterns.
Zhu Y; Wu R; Sangha N; Yoo C; Cho KR; Shedden KA; Katabuchi H; Lubman DM
Proteomics; 2006 Nov; 6(21):5846-56. PubMed ID: 17068758
[TBL] [Abstract][Full Text] [Related]
16. [Proteomic analysis of human ovarian cancer cell lines and their platinum-resistant clones].
Yan XD; Pan LY
Zhonghua Fu Chan Ke Za Zhi; 2006 Sep; 41(9):584-7. PubMed ID: 17181965
[TBL] [Abstract][Full Text] [Related]
17. [Early proteomics in ovarian cancer: myth or reality?].
Makarov OV; Govorun VM; Taranets IN; Goufman EI; Gritsaĭ AN; Archakov AI
Biomed Khim; 2003; 49(1):2-7. PubMed ID: 14569865
[TBL] [Abstract][Full Text] [Related]
18. Using proteomic approaches to identify new biomarkers for detection and monitoring of ovarian cancer.
Kong F; Nicole White C; Xiao X; Feng Y; Xu C; He D; Zhang Z; Yu Y
Gynecol Oncol; 2006 Feb; 100(2):247-53. PubMed ID: 16229881
[TBL] [Abstract][Full Text] [Related]
19. Proteomics of breast carcinoma.
Somiari RI; Somiari S; Russell S; Shriver CD
J Chromatogr B Analyt Technol Biomed Life Sci; 2005 Feb; 815(1-2):215-25. PubMed ID: 15652811
[TBL] [Abstract][Full Text] [Related]
20. [Comparative proteomics analysis of differentially expressed metastasis-associated proteins in human ovarian cancer cell lines].
Su D; Xu SH; Gu LH
Zhonghua Fu Chan Ke Za Zhi; 2005 Sep; 40(9):619-22. PubMed ID: 16202319
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
